Treatment of cocaine abuse during pregnancy: translating research to clinical practice.
In the late-1980s and early-1990s, much attention in America was focused on cocaine abuse. In particular, the effects of prenatal cocaine use on mothers and infants were in the news spotlight. Risks of adverse effects prompted funding for novel treatment programs. More recently, media attention has shifted elsewhere, and specialized treatment resources have grown scarce. This redirection of funding is unfortunate, as social stigma and fear of legal consequences continue to encourage cocaine-abusing pregnant women to hide drug use and avoid prenatal care. The purpose of this article is to summarize the most prominent adverse maternal and fetal/infant effects associated with prenatal cocaine use; review treatment options, focusing on comprehensive care programs of the 1990s as well as recent research on evidence-based practices and their applicability to pregnant women; and highlight the population of prenatal cocaine-abusing women uninterested in treatment, with a focus on promising strategies to promote drug abstinence and other positive health behaviors.
Hull
Lynn
L
Virginia Commonwealth University, Institute for Drug and Alcohol Studies, AWHARE (Addiction and Women's Health: Advancing Research and Evaluation) Program, Old City Hall, Richmond, VA 23298-0343, USA. hulllc@vcu.edu
May
James
J
Farrell-Moore
Dawn
D
Svikis
Dace S
DS
D019970:Cocaine-Related Disorders / Q000628:therapy*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011295:Prenatal Care; D011297:Prenatal Exposure Delayed Effects; D057545:Social Stigma